249 related articles for article (PubMed ID: 24759141)
1. Physiologic activities of the contact activation system.
Schmaier AH
Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
[TBL] [Abstract][Full Text] [Related]
2. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
Fang C; Schmaier AH
Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
[TBL] [Abstract][Full Text] [Related]
3. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
Schmaier AH
J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
[TBL] [Abstract][Full Text] [Related]
4. The Plasma Kallikrein-Kininogen Pathway Is Critical in the Pathogenesis of Colitis in Mice.
Wang B; Yang A; Zhao Z; He C; Liu Y; Colman RW; Dai J; Wu Y
Front Immunol; 2018; 9():21. PubMed ID: 29467753
[TBL] [Abstract][Full Text] [Related]
5. Assembly and activation of the plasma kallikrein/kinin system: a new interpretation.
Shariat-Madar Z; Mahdi F; Schmaier AH
Int Immunopharmacol; 2002 Dec; 2(13-14):1841-9. PubMed ID: 12489798
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
Front Immunol; 2020; 11():2014. PubMed ID: 32849666
[TBL] [Abstract][Full Text] [Related]
7. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
8. A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin-Angiotensin Systems.
Schmaier AH
Front Med (Lausanne); 2016; 3():61. PubMed ID: 27965959
[TBL] [Abstract][Full Text] [Related]
9. Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions.
Schmaier AH
Curr Opin Hematol; 2000 Sep; 7(5):261-5. PubMed ID: 10961574
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic potential of the contact activation pathway.
Schmaier AH
Curr Opin Hematol; 2016 Sep; 23(5):445-52. PubMed ID: 27380557
[TBL] [Abstract][Full Text] [Related]
11. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
Schmaier AH
Int Immunopharmacol; 2008 Feb; 8(2):161-5. PubMed ID: 18182220
[TBL] [Abstract][Full Text] [Related]
12. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system.
Taylor SL; Wahl-Jensen V; Copeland AM; Jahrling PB; Schmaljohn CS
PLoS Pathog; 2013; 9(7):e1003470. PubMed ID: 23874198
[TBL] [Abstract][Full Text] [Related]
14. The bradykinin-forming cascade and its role in hereditary angioedema.
Kaplan AP; Joseph K
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
[TBL] [Abstract][Full Text] [Related]
15. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2017 Jul; 140(1):170-176. PubMed ID: 27826093
[TBL] [Abstract][Full Text] [Related]
16. In vitro reconstitution of kallikrein-kinin system and progress curve analysis.
Favier B; Bicout DJ; Baroso R; Paclet MH; Drouet C
Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36156118
[TBL] [Abstract][Full Text] [Related]
17. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
Kaplan AP; Joseph K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087
[TBL] [Abstract][Full Text] [Related]
18. The bradykinin-forming cascade: a historical perspective.
Kaplan AP
Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
20. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
Steen Burrell KA; Layzer J; Sullenger BA
J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
